Systems Approaches to Cancer Biology Meeting

癌症生物学会议的系统方法

基本信息

项目摘要

SUMMARY The Systems Approaches to Cancer Biology (SACB) meeting aims to bring together scientific leaders and early-stage investigators in Cancer Systems Biology to build and foster a thriving and collaborative field by sharing scientific advances. Started as a grassroots effort from early-stage Cancer Systems Biology investigators, the first SACB meeting was held in 2016 and is held every other year. SACB has been sponsored by the National Cancer Institute and continues to be sponsored by the Association for Cancer Systems Biologists (ACSB). The meeting is solely focused on research topics that address cancer as inherently complex, with spatial, temporal, and interpatient heterogeneity, and with multifactorial causes and consequences that cannot be understood without integrating diverse approaches from a combination of traditional scientific disciplines. The SACB meeting consists of six plenary sessions, as well as poster sessions, special topic sessions, and many opportunities for early-stage investigators to network and gain mentorship from more senior investigators. SACB plenary sessions focus on many aspects of cancer biology and cover a diversity of computational/mathematical modeling approaches. This problem-domain-focused (as opposed to methods-focused) programming is particularly conducive to the synthesis of new ideas and collaborations among attendees. Given the history of this meeting, there is a strong emphasis on the development and fostering of early-stage investigators, which includes at least half of the oral presentations being given by trainees and addressing topics of interest to early-stage investigators through special topic sessions. Another focus of the meeting is to grow the Cancer Systems Biology community, which we will accomplish by targeting underserved research communities and reaching out to researchers in complementary topic areas, such as computer science or engineering. We will also provide funding support for early-stage investigators to attend the meeting, as well as funding support for investigators with additional family needs. SACB has successfully helped to advance the careers of many early-stage investigators and brings together like-minded scientists to share research findings. Moving forward, and building on a very successful virtual meeting in 2020, SACB will become a hybrid meeting, with both in-person and virtual meeting options. This will provide a venue for SACB to reach colleagues across the world and still be able to provide the intimate environment needed to foster Cancer Systems Biology research into the future.
总结 癌症生物学系统方法(SACB)会议旨在汇集科学领导者, 癌症系统生物学的早期研究人员,通过以下方式建立和培育一个蓬勃发展的合作领域: 分享科学进步。从早期癌症系统生物学的基层努力开始, 根据调查人员的说法,第一次SACB会议于2016年举行,每隔一年举行一次。SACB已经 由国家癌症研究所赞助,并继续由癌症协会赞助 系统生物学家(ACSB)。该会议仅集中于解决癌症的研究主题, 固有复杂性,具有空间、时间和患者间异质性,以及多因素原因, 如果不将各种方法结合起来,就无法理解这些后果, 传统科学学科。SACB会议包括六次全体会议,以及海报 会议,专题会议,并为早期研究者提供许多机会,以建立网络和获得 更多资深调查员的指导。SACB全体会议关注癌症生物学的许多方面 并涵盖多种计算/数学建模方法。这一问题领域的重点(如 与注重方法的做法相反, 与会者之间的合作。考虑到本次会议的历史, 发展和培养早期研究者,其中包括至少一半的口头报告 由受训人员讲授,并通过专题讨论解决早期研究人员感兴趣的问题 sessions.会议的另一个重点是发展癌症系统生物学社区,我们将 通过针对服务不足的研究社区,并以互补的方式与研究人员接触, 主题领域,如计算机科学或工程。我们亦会提供资助, 调查员出席会议,并为有额外家庭需要的调查员提供资金支持。 SACB成功地帮助许多早期调查人员的职业发展, 志同道合的科学家分享研究成果。向前迈进,并建立在一个非常成功的虚拟 SACB会议将于2020年举行,SACB将成为一个混合会议,既有面对面的会议,也有虚拟会议。这将 为SACB提供一个与世界各地的同事接触的场所,同时仍然能够提供亲密的 环境需要促进癌症系统生物学研究的未来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Christopher Costello其他文献

James Christopher Costello的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Christopher Costello', 18)}}的其他基金

NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer
NPEPPS 是膀胱癌化疗耐药的新型可药物决定因素
  • 批准号:
    10527232
  • 财政年份:
    2022
  • 资助金额:
    $ 2.58万
  • 项目类别:
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer
NPEPPS 是膀胱癌化疗耐药的新型可药物决定因素
  • 批准号:
    10662535
  • 财政年份:
    2022
  • 资助金额:
    $ 2.58万
  • 项目类别:
Curated prostate cancer data for novel and reproducible prognostic modeling
精心策划的前列腺癌数据用于新颖且可重复的预后模型
  • 批准号:
    9979264
  • 财政年份:
    2020
  • 资助金额:
    $ 2.58万
  • 项目类别:
Systems analysis of aggressive prostate cancer pathology
侵袭性前列腺癌病理学的系统分析
  • 批准号:
    10247753
  • 财政年份:
    2019
  • 资助金额:
    $ 2.58万
  • 项目类别:
Systems analysis of aggressive prostate cancer pathology
侵袭性前列腺癌病理学的系统分析
  • 批准号:
    10462763
  • 财政年份:
    2019
  • 资助金额:
    $ 2.58万
  • 项目类别:
Systems analysis of aggressive prostate cancer pathology
侵袭性前列腺癌病理学的系统分析
  • 批准号:
    10681271
  • 财政年份:
    2019
  • 资助金额:
    $ 2.58万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.58万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了